BNTX BioNTech SE

track record → $105.46 -0.10 (-0.1%)
Get emailed when BNTX changes direction
Mkt Cap $27B 52wk $79.52 - $124.00 Earnings 2026-05-05
Factor Model (net -0.5)

Factor Model

net -0.5
Est. Revisions
+0.5
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

Fundamentals & Data ▾
BioNTech SE Healthcare · Biotechnology
Mkt Cap
$27B
Beta
1.59
52w Range
$79.52 - $124.00
Short Interest
3.5M 5.13%
Days to Cover
2.0 -21%
Technicals downtrend
from 52w Hi
-5.5%
1w return
+2.5%
EPS Estimate
$-1.92 +7.7% 30d 0up / 3dn
Est. Dispersion
80% 3 analysts
Analyst Target
$131 $75 - $174
Options P/C
0.18
Fund Convergence
strong Citadel, Two Sigma, D.E. Shaw, Bridgewater
Financials
Revenue
$907M -24% YoY
FCF
$247M
Gross Margin
63%
Op Margin
-31%
Momentum: decelerating
Top Holders
Citadel $97M
Two Sigma $1M
D.E. Shaw $1M
Bridgewater
2 signals · latest Updated Friday

Get alerted when BNTX changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.